Status:
ACTIVE_NOT_RECRUITING
Efficacy and Safety of TORS for SCCA
Lead Sponsor:
Katherine L Fedder
Conditions:
Oropharyngeal Squamous Cell Carcinoma
Supraglottic Squamous Cell Carcinoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to learn more about the outcomes of treatment of throat and voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option involving the use of ...
Eligibility Criteria
Inclusion
- Adult male or female
- Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma
Exclusion
- Metastatic disease
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT01819480
Start Date
March 1 2013
End Date
December 1 2025
Last Update
February 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia Health System
Charlottesville, Virginia, United States, 22908